These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38132178)

  • 1. Repurposing Metabolic Inhibitors in the Treatment of Colon Adenocarcinoma Patient-Derived Models.
    Lee B; Lee C; Moon HM; Jo SY; Jang SJ; Suh YA
    Cells; 2023 Dec; 12(24):. PubMed ID: 38132178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenformin enhances the therapeutic benefit of BRAF(V600E) inhibition in melanoma.
    Yuan P; Ito K; Perez-Lorenzo R; Del Guzzo C; Lee JH; Shen CH; Bosenberg MW; McMahon M; Cantley LC; Zheng B
    Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18226-31. PubMed ID: 24145418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenformin, But Not Metformin, Delays Development of T Cell Acute Lymphoblastic Leukemia/Lymphoma via Cell-Autonomous AMPK Activation.
    Vara-Ciruelos D; Dandapani M; Russell FM; Grzes KM; Atrih A; Foretz M; Viollet B; Lamont DJ; Cantrell DA; Hardie DG
    Cell Rep; 2019 Apr; 27(3):690-698.e4. PubMed ID: 30995468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biguanides metformin and phenformin inhibit angiogenesis, local and metastatic growth of breast cancer by targeting both neoplastic and microenvironment cells.
    Orecchioni S; Reggiani F; Talarico G; Mancuso P; Calleri A; Gregato G; Labanca V; Noonan DM; Dallaglio K; Albini A; Bertolini F
    Int J Cancer; 2015 Mar; 136(6):E534-44. PubMed ID: 25196138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Pancreatic Cancer Patient-Derived Xenograft Panel with Metabolic Inhibitors Reveals Efficacy of Phenformin.
    Rajeshkumar NV; Yabuuchi S; Pai SG; De Oliveira E; Kamphorst JJ; Rabinowitz JD; Tejero H; Al-Shahrour F; Hidalgo M; Maitra A; Dang CV
    Clin Cancer Res; 2017 Sep; 23(18):5639-5647. PubMed ID: 28611197
    [No Abstract]   [Full Text] [Related]  

  • 6. Biguanides Metformin and Phenformin Generate Therapeutic Effects via AMP-Activated Protein Kinase/Extracellular-Regulated Kinase Pathways in an In Vitro Model of Graves' Orbitopathy.
    Han YE; Hwang S; Kim JH; Byun JW; Yoon JS; Lee EJ
    Thyroid; 2018 Apr; 28(4):528-536. PubMed ID: 29589999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metformin and phenformin on apoptosis and epithelial-mesenchymal transition in chemoresistant rectal cancer.
    Park JH; Kim YH; Park EH; Lee SJ; Kim H; Kim A; Lee SB; Shim S; Jang H; Myung JK; Park S; Lee SJ; Kim MJ
    Cancer Sci; 2019 Sep; 110(9):2834-2845. PubMed ID: 31278880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenformin Induces Cell Cycle Change, Apoptosis, and Mesenchymal-Epithelial Transition and Regulates the AMPK/mTOR/p70s6k and MAPK/ERK Pathways in Breast Cancer Cells.
    Liu Z; Ren L; Liu C; Xia T; Zha X; Wang S
    PLoS One; 2015; 10(6):e0131207. PubMed ID: 26114294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AMPK activators inhibit the proliferation of human melanomas bearing the activated MAPK pathway.
    Petti C; Vegetti C; Molla A; Bersani I; Cleris L; Mustard KJ; Formelli F; Hardie GD; Sensi M; Anichini A
    Melanoma Res; 2012 Oct; 22(5):341-50. PubMed ID: 22588166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin.
    Shackelford DB; Abt E; Gerken L; Vasquez DS; Seki A; Leblanc M; Wei L; Fishbein MC; Czernin J; Mischel PS; Shaw RJ
    Cancer Cell; 2013 Feb; 23(2):143-58. PubMed ID: 23352126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells.
    Janzer A; German NJ; Gonzalez-Herrera KN; Asara JM; Haigis MC; Struhl K
    Proc Natl Acad Sci U S A; 2014 Jul; 111(29):10574-9. PubMed ID: 25002509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1.
    Liu X; Gan B
    Cell Cycle; 2016 Dec; 15(24):3471-3481. PubMed ID: 27792451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenformin as prophylaxis and therapy in breast cancer xenografts.
    Appleyard MV; Murray KE; Coates PJ; Wullschleger S; Bray SE; Kernohan NM; Fleming S; Alessi DR; Thompson AM
    Br J Cancer; 2012 Mar; 106(6):1117-22. PubMed ID: 22361631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the contribution of AMP-activated protein kinase (AMPK) and protein kinase C (PKC) in regulation of glucose uptake by metformin in skeletal muscle cells.
    Turban S; Stretton C; Drouin O; Green CJ; Watson ML; Gray A; Ross F; Lantier L; Viollet B; Hardie DG; Marette A; Hundal HS
    J Biol Chem; 2012 Jun; 287(24):20088-99. PubMed ID: 22511782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of phenformin in non-small cell lung cancer (NSCLC) ionizing radiation treatment.
    Wang J; Xia S; Zhu Z
    Cell Biochem Biophys; 2015 Mar; 71(2):513-8. PubMed ID: 25312480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of gain-of-function mutant p53 with metabolic inhibitors reduces tumor growth in vivo.
    Jung CL; Mun H; Jo SY; Oh JH; Lee C; Choi EK; Jang SJ; Suh YA
    Oncotarget; 2016 Nov; 7(47):77664-77682. PubMed ID: 27765910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic Repurposing of Biguanides in Cancer.
    Zhao H; Swanson KD; Zheng B
    Trends Cancer; 2021 Aug; 7(8):714-730. PubMed ID: 33865798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor Properties of RAF709, a Highly Selective and Potent Inhibitor of RAF Kinase Dimers, in Tumors Driven by Mutant RAS or BRAF.
    Shao W; Mishina YM; Feng Y; Caponigro G; Cooke VG; Rivera S; Wang Y; Shen F; Korn JM; Mathews Griner LA; Nishiguchi G; Rico A; Tellew J; Haling JR; Aversa R; Polyakov V; Zang R; Hekmat-Nejad M; Amiri P; Singh M; Keen N; Dillon MP; Lees E; Ramurthy S; Sellers WR; Stuart DD
    Cancer Res; 2018 Mar; 78(6):1537-1548. PubMed ID: 29343524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin.
    Hung LVM; Moon JY; Ryu JY; Cho SK
    Phytomedicine; 2019 Oct; 63():153000. PubMed ID: 31280139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenformin and ataxia-telangiectasia mutated inhibitors synergistically co-suppress liver cancer cell growth by damaging mitochondria.
    Wu T; Zhou S; Qin M; Tang J; Yan X; Huang L; Huang M; Deng J; Xiao D; Hu X; Wu J; Yang X; Li G
    FEBS Open Bio; 2021 May; 11(5):1440-1451. PubMed ID: 33742560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.